Humanigen Expands Phase III Study of Lenzilumab in COVID-19 to Brazil

August 10, 2020August 10, 2020 THE COVID REMEDY trials

“Access to clinical trials is critical for healthcare providers in the fight against COVID-19,” remarked Timothy Schroeder, chief executive officer of CTI.

Source: Humanigen Expands Phase III Study of Lenzilumab in COVID-19 to Brazil